SNDX Earnings

SNDX reported its FY2025Q3 earnings on 2025-11-03, showcasing a revenue of 46.00M against an estimate of 48.00M, resulting in a -4.38% surprise. The EPS was -0.7, surpassing the expected -0.74 by 5.41% . The stock experienced a 11.56% price change on the earnings day and a 9.3% change over the next five days, reflecting market reactions to the results.

Following SNDX's FY2025Q3 earnings announcement on 2025-11-03, the stock price moved by 11.56% on the day of the release. Over the subsequent five days, it saw a 9.30% change. Historically, SNDX's stock price tends to shift by an average of -3.65% in the 10 days leading up to earnings and -1.97% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate SNDX’s annual revenue to reach 64.00M, while the EPS is projected at -1.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -1.54% and EPS estimates Revise Downward by -0.86% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between SNDX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -1.54%, while EPS estimates moved Revise Downward by -0.86% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, SNDX's stock price typically moves by -3.65% in the 10 days before its earnings and -1.97% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of -1.00 and revenue of 64.00M.

The earnings call summary highlights strong financial performance, product development, and market strategy, with optimistic guidance and shareholder return plans. The Q&A section provides additional positive insights, such as excellent payer access and a consistent safety profile for Revuforj. The strategic plan indicates significant growth opportunities, including market expansion and profitability outlook. Considering the company's strong market position, upcoming product approvals, and positive financial health, the stock is likely to see a positive movement in the short term.